Ryzodeg Quiz Skt

CVOT of Insulin Degludec (i.e Devote), demonstrates _______% rate reduction in terms of nocturnal severe hypoglycaemia.

• 40%

• 45%

• 50%

• 54%

CVOT of Insulin Degludec (i.e Devote), demonstrates _______% rate reduction in terms of severe hypoglycaemia.

• 40%

• 50%

• 30%

• 54%

DEVOTE is a double-blinded cardiovascular outcomes trial with the comparison of insulin degludec versus placebo.

• True

• False

Patients switching from once daily basal or premix insulin therapy can be converted unit-to-unit to twice daily Ryzodeg® at the same total insulin dose as the patient’s previous total daily insulin dose.

• True

• False

Ryzodeg® is not indicated in

• Patients with renal or hepatic impairment

• Children

• Pregnancy

• LADA

How long before steady state is achieved following a dose administration of Ryzodeg^®?

• Around 2 Days

• Around 3 Days

• Upto 42 Hours

• None of these

What are the key differentiators between Ryzodeg^® and insulin glargine? (Choose All that Apply)

• Once Daily Dosing

• Contains ultra-long-acting insulin

• Start with 10 Units

• Targets both FBG and PPG

Real world study can be done in multiple countries simultaneously?

• True

• False

Which organization recommendation of TiR is part of its promotional campaign?

• AACE/IDF

• ADA

• UKPDS

• EASD

How much time is recommended to be spent in range by ADA?

• 65%

• 70%

• 72%

• 50%